Collectively, the above data demonstrate that while SCD undergoes epigenetic silencing and monoallelic co-deletion in a subset of PTEN-deleted cancer leading to significant loss of expression, residual SCD activity is present in these cells but inessential for their growth and viability. The gene discussed is SCD; the disease is cancer.